Sanofi SNY
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | 13.49B | 13.16B | 14.54B | 11.34B | |
| Total Other Revenue | 817.64M | 1.05B | 860.47M | 840.98M | |
| Total Revenue | 14.31B | 14.21B | 15.40B | 12.18B | |
| Cost of Revenue | 3.36B | 4.23B | 3.99B | 3.40B | |
| Gross Profit | 10.95B | 9.98B | 11.41B | 8.79B | |
| SG&A Expenses | 2.90B | 3.28B | 2.68B | 2.63B | |
| Depreciation & Amortization | 642.02M | 626.28M | 538.96M | 429.00M | |
| Other Operating Expenses | 1.80B | 1.38B | 1.62B | 1.62B | |
| Total Operating Expenses | 11.30B | 12.18B | 10.97B | 10.24B | |
| Operating Income | 3.01B | 2.03B | 4.42B | 1.94B | |
| Income Before Tax | 963.03M | -1.34B | 4.10B | 1.66B | |
| Income Tax Expenses | 524.55M | -405.11M | 795.00M | 261.03M | |
| Earnings from Continuing Operations | 438.48M | -939.43M | 3.31B | 1.40B | |
| Earnings from Discontinued Operations | 0.00 | 15.13M | -23.38M | 3.07B | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -39.54M | -8.15M | -7.01M | -4.54M | |
| Net Income | 398.94M | -932.44M | 3.28B | 4.47B | |
| EBIT | 3.01B | 2.03B | 4.42B | 1.94B | |
| EBITDA | 4.45B | 4.06B | 4.91B | 2.87B | |
| EPS Basic | 0.33 | -0.77 | 2.69 | 3.67 | |
| Normalized Basic EPS | 1.42 | 1.02 | -- | 1.01 | |
| EPS Diluted | 0.33 | -0.77 | 2.69 | 3.67 | |
| Normalized Diluted EPS | 1.42 | 1.02 | -- | 1.01 | |
| Average Basic Shares Outstanding | 1.20B | 1.21B | 1.22B | 1.22B | |
| Average Diluted Shares Outstanding | 1.20B | 1.21B | 1.22B | 1.22B | |
| Dividend Per Share | -- | 4.80 | -- | -- | |
| Payout Ratio | 1,435.28% | -595.76% | -- | 121.12% | |